|
SYNCRIP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.670400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.315150E-01 |
| Normal-vs-Stage2 |
7.696300E-02 |
| Normal-vs-Stage3 |
4.782100E-03 |
| Normal-vs-Stage4 |
2.942100E-02 |
| Stage1-vs-Stage2 |
3.834800E-01 |
| Stage1-vs-Stage3 |
6.586500E-02 |
| Stage1-vs-Stage4 |
2.366600E-01 |
| Stage2-vs-Stage3 |
8.338000E-01 |
| Stage2-vs-Stage4 |
9.687600E-01 |
| Stage3-vs-Stage4 |
7.369600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.593890E-02 |
| Normal-vs-AfricanAmerican |
1.285650E-02 |
| Normal-vs-Asian |
5.068400E-01 |
| Caucasian-vs-AfricanAmerican |
3.919400E-01 |
| Caucasian-vs-Asian |
8.722200E-01 |
| AfricanAmerican-vs-Asian |
6.022600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.643500E-03 |
| Normal-vs-Female |
2.569800E-01 |
| Male-vs-Female |
2.893600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.650000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.113600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.176340E-02 |
| Normal-vs-Age(81-100Yrs) |
1.490350E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.686200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.016800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.458800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.235800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.789160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.749800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.602200E-01 |
| Normal-vs-Grade 2 |
2.600200E-01 |
| Normal-vs-Grade 3 |
1.678290E-03 |
| Normal-vs-Grade 4 |
2.523100E-03 |
| Grade 1-vs-Grade 2 |
1.599200E-01 |
| Grade 1-vs-Grade 3 |
7.384400E-03 |
| Grade 1-vs-Grade 4 |
1.114160E-02 |
| Grade 2-vs-Grade 3 |
1.063960E-02 |
| Grade 2-vs-Grade 4 |
1.804350E-02 |
| Grade 3-vs-Grade 4 |
4.480200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.599200E-01 |
| Normal-vs-ccB subtype |
2.103200E-03 |
| ccA subtype-vs-ccB subtype |
1.647000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.580300E-02 |
| Normal-vs-N1 |
4.157000E-01 |
| N0-vs-N1 |
8.732800E-01 |
|
|
